I care, we care
BanGel can load different types of medicines, incl. both Hydrophilic & Hydrophobic, Small Molecules & Large Molecules, Mono-compound & Compounds mixture
Up to 100% drug release in 24 hours, with controllable release rate possibilities
Waterproof, elongation, durability, skin affinity, limited costs, biodegradability
The limitations of transdermal drug delivery solutions in the market are low drug loading and release efficiency, inferior durability, and short curative period), like plaster, cream, gel, and other hydrogel.
Ph.D Dr.Yan has been the Chief Executive Officer and Chief Technical Officer since its foundation in 2020. His role on the team consists of commercial management, general administration, and R&D.
Ph.D Dr.Bai has been the Chief Technical Officer since its foundation in 2020. Her role on the team consists of R&D product development in pharmacology, especially for the product in preclinical and clinical research.
Mr. Qiu mainly focuses on the day-to-day operations and investor relationship management in Bang Nanobiotech s.r.l.
Mrs Cai is one of the co-founders and is currently the Chief Marketing Officer of Bang Nanobiotech s.r.l.
Mr. Xu is responsible for the corporate strategy definition & implementation, and overall organizational & governance process design and implementation in Bang Nanobiotech.
Mrs. Chu mainly focuses on the work of investor relations management & coordination in Bang Nanobiotech.
Our startup has been selected for the next phase of the BIND 4.0 Open Innovation & Acceleration program Selection process.
Bang Nanobiotech developed an innovative dressing material in Wound Care, which is the first-time breakthrough in the past 30 years and gives a life-changing experience to patients.